Coronavirus (COVID-19): What the Tuberculosis (TB) community can learn
Progress in Drug Discovery & Biomedical Science · 2020
DOI: 10.36877/pddbs.a0000090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Drug Discovery & Biomedical Science, 2020. Verfasst von Shaun Wen Huey Lee. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The coronavirus disease (COVID-19) outbreak which started in late 2019 was announced as a global pandemic by World Health Organisation in March 2020. Government around the world began to implement various measures including economic stimulus packages as well as movement restrictions in an effort to limit the spread of this disease. This paper aims to discuss some of the learnings and perspective of benefits, future opportunities that can be applied to tuberculosis care, in an effort to meet the World Health Organisation End — TB strategy.
Zitieren
APA
Lee, S. W. H. (2020). Coronavirus (COVID-19): What the Tuberculosis (TB) community can learn. Progress in Drug Discovery & Biomedical Science. https://doi.org/10.36877/pddbs.a0000090
Vancouver
Lee SWH. Coronavirus (COVID-19): What the Tuberculosis (TB) community can learn. Progress in Drug Discovery & Biomedical Science. 2020. doi:10.36877/pddbs.a0000090
BibTeX
@article{Lee2020,
author = {Lee, Shaun Wen Huey},
title = {Coronavirus (COVID-19): What the Tuberculosis (TB) community can learn},
journal = {Progress in Drug Discovery & Biomedical Science},
year = {2020},
doi = {10.36877/pddbs.a0000090}
}
EUVIMED